Sector revisions Scholar Rock Holding Corporation

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-06 EDT			5-day change	1st Jan Change
52.64 ^USD	+9.96%		+7.45%	+19.50%

08-06	Scholar Rock Holding Corporation, Q2 2026 Earnings Call, Aug 06, 2026
08-06	Scholar Rock Holding Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	SCHOLAR ROCK HOLDING CORPORATION							16
	WUXI APPTEC CO., LTD.							18
	ARGENX SE							15
	BIONTECH SE							20
	INSMED INCORPORATED							22
	WUXI BIOLOGICS (CAYMAN) INC.							23
	GENMAB A/S							15
	PHARMAESSENTIA CORPORATION							7
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							17
	EXELIXIS, INC.							16
	ARROWHEAD PHARMACEUTICALS, INC.							11
	MADRIGAL PHARMACEUTICALS, INC.							16
	AKESO, INC.							20
	SUMMIT THERAPEUTICS INC.							13
	CYTOKINETICS, INCORPORATED							20
	CRINETICS PHARMACEUTICALS, INC.							10
	REMEGEN CO., LTD.							15
	VAXCYTE, INC.							9
	IMMUNITYBIO, INC.							4
	Average							15
	Weighted average by Cap.							16